• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alnylam Pharmaceuticals

Alnylam Pharmaceuticals

  1. All
  2. 3rd Party
  1. Alnylam Pharma stock rises 1.5% after FDA gives drug 'breakthrough therapy' designation

    Alnylam Pharma stock rises 1.5% after FDA gives drug 'breakthrough therapy' designation

  2. BIO Elects John Maraganore, Ph.D., as New Chair

    BIO Elects John Maraganore, Ph.D., as New Chair

  3. Alnylam Significantly Expands Patent Portfolio with New Allowances from United States Patent and Trademark Office

    Alnylam Significantly Expands Patent Portfolio with New Allowances from United States Patent and Trademark Office

  4. Dodge & Cox Balanced Fund Isn't for Everyone

    This Gold-rated fund is not a safe choice, but it's a strong one for the right kind of investor.

  5. Investing in Hidden Assets

    Use this screen to find high-growth businesses that have big ideas to keep competitors at bay.

©2017 Morningstar Advisor. All right reserved.